Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Frame PrEP as part of a ‘healthy sex life’ for better adherence

Brief, empowering messaging around pre-exposure prophylaxis (PrEP) can lead to better medication adherence, new research has found. When PrEP counselors framed PrEP as part of a healthy sex life, new PrEP clients were significantly more likely to have high levels of adherence to the medication. This was true even among demographics that typically struggle with adherence including young people and people of color.

Published
19 hours ago
From
BETA blog
Bone density improves in people who switch from tenofovir DF to tenofovir alafenamide

After three years, tenofovir alafenamide (TAF) for first-line HIV treatment was better at suppressing viral load and safer for the bones and kidneys than the older tenofovir

Published
22 hours ago
By
Liz Highleyman
Should Antiretroviral Therapy be Offered the Same Day as Diagnosis?

Andy Seale summarizes a discussion that took place on ITPC’s listserv about when to initiate antiretroviral therapy. The discussion included consideration of WHO’s recommendation for Same Day Start.

Published
23 March 2017
From
ITPC
Research helps explain how vedolizumab antibody therapy leads to sustained viral remission

HIV and its monkey cousin SIV can carry the alpha-4 beta-7 integrin receptor in their outer envelope, which helps the virus enter gut cells during early infection,

Published
23 March 2017
By
Liz Highleyman
Hidden HIV reservoirs exposed by telltale protein

The discovery helps to identify dormant infected cells and could one day lead to a cure.

Published
21 March 2017
From
Nature
Mariëtte Botes: ARV pioneer who became the victim of abuse and hostility

Dr Mariëtte Botes, who has died in Pretoria at the age of 50, was an early pioneer of antiretroviral cocktails that saved the lives of hundreds of thousands of people with Aids. But, reports The Times, while running a clinical trial at Kalafong Hospital in Pretoria in 1999, she became the target of a hostile campaign by Patricia de Lille, who was then an MP for the PAC, who accused her of abusing and exploiting her patients.

Published
16 March 2017
From
Medical Brief
Several new candidates in HIV drug pipeline discussed at conference

This year's Conference on Retroviruses and Opportunistic Infections (CROI 2017), held last month in Seattle, included presentations on several new investigational antiretroviral drugs in development, reflecting a more

Published
15 March 2017
By
Liz Highleyman
Advanced HIV disease & Same day start of ART - Make your voice heard!

The World Health Organization is seeking the values & preferences of people living with HIV as it prepares new guidelines on two topics: whether ART should be started on the same day of a diagnosis of HIV, and the best combination of treatment for people living with HIV who look for care when they already have advanced HIV disease. Deadline: this Sunday, 19 March 2017.

Published
14 March 2017
From
WHO
Monkeys suppress HIV-like virus for extended period after dual-antibody treatment

Giving monkeys two powerful anti-HIV antibodies immediately after infection with an HIV-like virus enabled the immune systems of some of the animals to control the virus long after the antibodies were gone, scientists at the National Institutes of Health and The Rockefeller University have found.

Published
14 March 2017
From
Eurekalert Inf Dis
Early adherence to ART key to long-term virological outcomes

Adherence to antiretroviral therapy (ART) in the first few months after starting treatment is crucial to the long-term outcomes, French research published in the online

Published
14 March 2017
By
Michael Carter
← First12345...439Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.